Should we consider a 'fourth 90' for tuberculosis?
<h2>SUMMARY</h2>The international community has committed to end the tuberculosis (TB) epidemic by 2030. To facilitate the meeting of the global incidence and mortality indicators set by the World Health Organization&apos;s End TB Strategy, the Stop TB Partnership launched the three 90-(90)-90 diagnostic and treatment targets in 2014. In this paper, we argue that a &lsquo;fourth 90&rsquo;&mdash;Ensuring that 90&percnt; of all people successfully completing treatment for TB can have a good health-related quality of life&apos;&mdash;should be considered. Many individuals who successfully complete anti-TB treatment are burdened with lifelong comorbidities&mdash;human immunodeficiency virus (HIV) and diabetes mellitus, obstructive and restrictive lung disease, involving lung destruction, cavitation, fibrosis and bronchiectasis, that either pre-existed or developed as a result of TB (e.g., chronic pulmonary aspergillosis), permanent disabilities such as hearing loss resulting from second-line anti-TB drugs, and mental health disorders. These need to be identified during TB treatment and appropriate care and support provided after anti-TB treatment is successfully completed. A &lsquo;fourth 90&rsquo; has also been proposed for the UNAIDS 90-90-90 targets similar in scope to what is being suggested here for TB. Adoption by both HIV and TB control programmes would highlight the current focus on integrated person- and family-centred services.